CELESTONE SOLUSPAN
LOE Approachingbetamethasone acetate and betamethasone sodium phosphate
NDAINJECTIONINJECTABLE
Approved
Mar 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
CELESTONE SOLUSPAN (betamethasone acetate and betamethasone sodium phosphate) by Merck & Co. is clinical pharmacology glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Approved for dermatomyositis, polymyositis, systemic lupus erythematosus and 16 more indications. First approved in 1965.
Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CELESTONE SOLUSPAN is a dual-ester corticosteroid injection combining betamethasone acetate (sustained-release) and betamethasone sodium phosphate (immediate-release) for potent anti-inflammatory effects. It treats autoimmune, allergic, and inflammatory conditions including lupus, rheumatoid arthritis, asthma, ulcerative colitis, and severe allergic reactions. The 16β-methyl group enhances anti-inflammatory potency while reducing sodium and water retention typical of older steroids.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), signaling transition from growth to defensive positioning and potential team restructuring.
Mechanism of Action
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement…
Indications (19)
Worked on CELESTONE SOLUSPAN at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.